Therapeutics and Targets: Drug Mechanisms and Resistance

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 43 total displayed.

Most recent content

Reviews
The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting

Paolo Lunghi, Antonio Costanzo, Laura Mazzera, Vittorio Rizzoli, Massimo Levrero, and Antonio Bonati
Clin. Cancer Res. 2009; 15: 6495-6502. [Abstract] [Full text] [PDF]  

Past content

Review
Guiding the Optimal Translation of New Cancer Treatments From Canine to Human Cancer Patients

Chand Khanna, Cheryl London, David Vail, Christina Mazcko, and Steven Hirschfeld
Clin. Cancer Res. 2009; 15: 5671-5677. [Abstract] [Full text] [PDF]  

Minireviews
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance

Edith A. Perez
Mol. Cancer Ther. 2009; 8: 2086-2095. [Abstract] [Full text] [PDF]  

Subject Reviews
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy

Guido Frosina
Mol. Cancer Res. 2009; 7: 989-999. [Abstract] [Full text] [PDF]  

Reviews
Therapeutic Potential of "Rexinoids" in Cancer Prevention and Treatment

Takemi Tanaka and Luigi M. De Luca
Cancer Res. 2009; 69: 4945-4947. [Abstract] [Full text] [PDF]  

Heidelberger Symposium
Thymidylate synthase gene variations: predictive and prognostic markers

Georg Lurje, Philipp C. Manegold, Yan Ning, Alexandra Pohl, Wu Zhang, and Heinz-Josef Lenz
Mol. Cancer Ther. 2009; 8: 1000-1007. [Abstract] [Full text] [PDF]  

Review
Antivascular Actions of Microtubule-Binding Drugs

Edward L. Schwartz
Clin. Cancer Res. 2009; 15: 2594-2601. [Abstract] [Full text] [PDF]  

Reviews
On the Role of Cell Signaling Models in Cancer Research

Alejandra C. Ventura, Trachette L. Jackson, and Sofia D. Merajver
Cancer Res. 2009; 69: 400-402. [Abstract] [Full text] [PDF]  

Reviews
Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies

Charles Dumontet, Mary Ann Jordan, and Francis F.Y. Lee
Mol. Cancer Ther. 2009; 8: 17-25. [Abstract] [Full text] [PDF]  

Reviews
Drug Resistance Caused by Reversion Mutation

Alan Ashworth
Cancer Res. 2008; 68: 10021-10023. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5